Once-Weekly Insulin Icodec Bests Daily Insulin Options for Type 2 Diabetes

(MedPage Today) -- SAN DIEGO -- Investigational once-weekly insulin icodec outperformed once-daily insulin glargine U100 when it came to glycemic control in type 2 diabetes, the phase IIIa ONWARDS 1 trial found. Over the course of 52 weeks...

https://www.medpagetoday.com/meetingcoverage/ada/105183

Source: MedPage Today Primary Care - June 25, 2023 Category: Primary Care Source Type: news